The use of ADHD medication in Major League Baseball is under scrutiny, with a startling decline in exemptions. But is this a cause for celebration or concern?
A record-breaking low: Only 54 players received permission to use ADHD medication in 2025, a significant drop from the previous years. This number is a stark contrast to the 119 exemptions granted in 2013, leaving many wondering about the reasons behind this trend. And here's where it gets controversial—is this a sign of improved health management, or could it indicate potential loopholes in the system?
The Drug Testing Saga: The annual report by Thomas M. Martin sheds light on the drug testing program's intricacies. In the year leading up to the 2025 World Series, 11,700 drug tests were conducted, a mere 83 tests short of the record set in 2023. This rigorous testing included urine and blood samples, with a focus on detecting Human Growth Hormone.
Positive Tests and Penalties: Among the players on 40-man rosters, two positive tests led to disciplinary actions. Atlanta Braves' Jurickson Profar and Philadelphia Phillies' José Alvarado faced 80-game suspensions for Chorionic Gonadotrophin and external testosterone, respectively. Both players denied intentional use, with Alvarado's case attributed to a weight loss drug.
Exemptions and Beyond: Besides the 54 ADHD exemptions, there were also rare approvals for hypertension, sleep disorder, and hormone function. This raises questions about the criteria for granting such exemptions and the potential impact on player performance and health.
The declining trend in ADHD medication exemptions has sparked curiosity and debate. Are players finding alternative ways to manage their conditions, or is there a need to reevaluate the exemption process? Share your thoughts on this intriguing development in the world of sports medicine.
